Evaluation of Rational Drug Use Based on WHO/INRUD Core Drug Use Indicators in a Secondary Care Hospital: A Cross-Sectional Study in Western Uganda

References

• Sisay M, Mengistu G, Molla B, Amare F, Gabriel T. Evaluation of rational drug use based on World Health Organization core drug use indicators in selected public hospitals of eastern Ethiopia: a cross sectional study. BMC Health Serv Res. 2017;17(1):161. doi:10.1186/s12913-017-2097-3
   PubMedGoogle Scholar
• Huo H, Li X, Li H, et al. Analysis of rational drug use effect under hospital drug control system. Comput Math Methods Med. 2022;2022:1–6. doi:10.1155/2022/2927606
   Web of Science ®Google Scholar
• Sisay M, Mengistu G, Molla B, Amare F, Gabriel T, Devi Sagili K. Evaluation of rational drug use based on World Health Organization core drug use indicators in selected public hospitals of eastern Ethiopia: a cross sectional study. BMC Health Serv Res. 2017;17:1–9. doi:10.1186/s12913-017-2097-3
   PubMed Web of Science ®Google Scholar
• Sweileh WM. Global research publications on irrational use of antimicrobials: call for more research to contain antimicrobial resistance. Global Health. 2021;17(1):94. doi:10.1186/s12992-021-00754-9
   PubMed Web of Science ®Google Scholar
• Inform M, Mak D, Wendie TF, Ahmed A, Mohammed SA, Ghaffari F. Drug use pattern using WHO core drug use indicators in public health centers of Dessie. BMC Med Inform Decis Mak. 2021;21:1–10. doi:10.1186/s12911-021-01530-w
   PubMed Web of Science ®Google Scholar
• Kshirsagar NA. Rational use of medicines: cost consideration & way forward. Indian J Med Res. 2016;144(4):502–505. doi:10.4103/0971-5916.200901
   PubMedGoogle Scholar
• Ahmed B, Nanji K, Mujeeb R, Patel MJ. Effects of polypharmacy on adverse drug reactions among geriatric outpatients at a tertiary care hospital in Karachi: a prospective cohort study. PLoS One. 2014;9(11):e112133. doi:10.1371/journal.pone.0112133
   PubMed Web of Science ®Google Scholar
• Atif M, Asghar S, Mushtaq I, et al. What drives inappropriate use of antibiotics? A mixed methods study from Bahawalpur, Pakistan. Infect Drug Resist. 2019;12:687–699. doi:10.2147/IDR.S189114
   PubMed Web of Science ®Google Scholar
• Pépin J, Abou Chakra CN, Pépin E, Nault V, Valiquette L. Evolution of the global burden of viral infections from unsafe medical injections, 2000–2010. PLoS One. 2014;9(6):e99677. doi:10.1371/journal.pone.0099677
   PubMed Web of Science ®Google Scholar
• Kanagasabai U, Singh A, Shiraishi RW, et al. Improving injection safety practices of Cambodian healthcare workers through training. PLoS One. 2020;15(10):e0241176. doi:10.1371/journal.pone.0241176
   PubMed Web of Science ®Google Scholar
• Wiedenmayer K, Ombaka E, Kabudi B, et al. Adherence to standard treatment guidelines among prescribers in primary healthcare facilities in the Dodoma region of Tanzania. BMC Health Serv Res. 2021;21(1):272. doi:10.1186/s12913-021-06257-y
   PubMed Web of Science ®Google Scholar
• Melku L, Wubetu M, Dessie B. Irrational drug use and its associated factors at Debre Markos referral Hospital’s outpatient pharmacy in East Gojjam, Northwest Ethiopia. SAGE Open Med. 2021;9:20503121211025144. doi:10.1177/20503121211025146
   Web of Science ®Google Scholar
• Atif M, Sarwar MR, Azeem M, Naz M, Amir S, Nazir K. Assessment of core drug use indicators using WHO/INRUD methodology at primary healthcare centers in Bahawalpur, Pakistan. BMC Health Serv Res. 2016;16(1):684. doi:10.1186/s12913-016-1932-2
   PubMed Web of Science ®Google Scholar
• Kwesiga B, Wagner AK, Seru M, Ross-Degnan D, Trap B. Costs and effectiveness of the supervision, performance assessment and recognition (SPARS) strategy for medicines management in Uganda. J Pharm Policy Pract. 2019;12(1):36. doi:10.1186/s40545-019-0196-8
   PubMed Web of Science ®Google Scholar
• Trap B, Ladwar DO, Oteba MO, Embrey M, Khalid M, Wagner AK. Article 1: Supervision, Performance Assessment, and Recognition Strategy (SPARS) - A multipronged intervention strategy for strengthening medicines management in Uganda: method presentation and facility performance at baseline. J Pharm Policy Pract. 2016;9(1):21. doi:10.1186/s40545-016-0070-x
   PubMedGoogle Scholar
• Ladwar DO, Sembatya MN, Amony NM, et al. Article 4: impact assessment of supervision performance assessment and recognition strategy (SPARS) to improve supply chain management in health facilities in Uganda: a national pre and post study. J Pharm Policy Pract. 2021;14(1):14. doi:10.1186/s40545-020-00290-8
   PubMed Web of Science ®Google Scholar
• Management Sciences for Health. Supervision, performance assessment, and recognition strategy: how SPARS is improving health services across Uganda. Available from: https://msh.org/resources/supervision-performance-assessment-and-recognition-strategy-how-spars-is-improving-health/. Accessed May 31, 2023.
   Google Scholar
• Prasad PS, Rudra J, Vasanthi P, Sushitha U, Sadiq MJ, Narayana G. Assessment of drug use pattern using World Health Organization core drug use indicators at secondary care referral hospital of South India. CHRISMED J Health Res. 2015;2(3):223. doi:10.4103/2348-3334.158683
   Google Scholar
• Tassew SG, Abraha HN, Gidey K, Gebre AK. Assessment of drug use pattern using WHO core drug use indicators in selected general hospitals: a cross-sectional study in Tigray region, Ethiopia. BMJ Open. 2021;11(10):e045805. doi:10.1136/bmjopen-2020-045805
   PubMed Web of Science ®Google Scholar
• Nyabuti AO, Okalebo FA, Guantai EM. Examination of WHO/INRUD core drug use indicators at Public Primary Healthcare Centers in Kisii County, Kenya. Adv Pharmacol Pharm Sci. 2020;2020:1–7. doi:10.1155/2020/3173847
   Google Scholar
• Ogbonna BO, Enyi-Okafor AS, Okoye MI, et al. Assessment of drug use in a tertiary hospital in Southeast Nigeria based on who core drug use indicators. Austin J Nurs Health Care. 2022;9(2):1072–1075. doi:10.26420/austinjnurshealthcare.2022.1072
   Google Scholar
• Siele SM, Abdu N, Ghebrehiwet M, Hamed MR, Tesfamariam EH. Drug prescribing and dispensing practices in regional and national referral hospitals of Eritrea: evaluation with WHO/INRUD core drug use indicators. PLoS One. 2022;17(8):e0272936. doi:10.1371/journal.pone.0272936
   PubMed Web of Science ®Google Scholar
• Akl OA, El Mahalli AA, Elkahky AA, Salem AM. WHO/INRUD drug use indicators at primary healthcare centers in Alexandria, Egypt. J Taibah Univ Medical Sci. 2014;9(1):54–64. doi:10.1016/j.jtumed.2013.06.002
   Google Scholar
• El Mahalli AA. WHO/INRUD drug prescribing indicators at primary health care centres in Eastern province, Saudi Arabia. East Mediterr Health J. 2012;18(11):1091–1096. doi:10.26719/2012.18.11.1091
   PubMedGoogle Scholar
• Ahmed SA, Hamedelniel EI, Yousif AK. Assessing drug use indicators in health insurance facilities, Gezira State, Sudan, 2017–2018. PP. 2021;12(10):237–246. doi:10.4236/pp.2021.1210020
   Google Scholar
• Meena DK, Mathaiyan J, Thulasingam M, Ramasamy K. Assessment of medicine use based on WHO drug‐use indicators in public health facilities of the South Indian Union Territory. Brit J Clin Pharm. 2022;88(5):2315–2326. doi:10.1111/bcp.15165
   PubMed Web of Science ®Google Scholar
• El-Dahiyat F, Salah D, Alomari M, Elrefae A, Jairoun AA. Antibiotic Prescribing Patterns for Outpatient Pediatrics at a Private Hospital in Abu Dhabi: a Clinical Audit Study. Antibiotics. 2022;11(12):1676. doi:10.3390/antibiotics11121676
   Google Scholar
• Administration (TGA). Prescription medicines overview. Therapeutic Goods Administration (TGA); 2022. Available from: https://www.tga.gov.au/resources/resource/guidance/prescription-medicines-overview. Accessed May 31, 2023.
   Google Scholar
• Guthrie B, Makubate B, Hernandez-Santiago V, Dreischulte T. The rising tide of polypharmacy and drug-drug interactions: population database analysis 1995–2010. BMC Med. 2015;13(1):74. doi:10.1186/s12916-015-0322-7
   PubMed Web of Science ®Google Scholar
• Dhingra S, Rahman NAA, Peile E, et al. Microbial resistance movements: an overview of global public health threats posed by antimicrobial resistance, and how best to counter. Front Public Health. 2020;8:535668. doi:10.3389/fpubh.2020.535668
   PubMed Web of Science ®Google Scholar
• Ayukekbong JA, Ntemgwa M, Atabe AN. The threat of antimicrobial resistance in developing countries: causes and control strategies. Antimicrob Resist Infect Control. 2017;6(1):47. doi:10.1186/s13756-017-0208-x
   PubMed Web of Science ®Google Scholar
• Bosu WK, Ofori-Adjei D. An audit of prescribing practices in health care facilities of the Wassa West district of Ghana. West Afr J Med. 2000;19(4):298–303.
   PubMedGoogle Scholar
• Hauri AM, Armstrong GL, Hutin YJF. The global burden of disease attributable to contaminated injections given in health care settings. Int J STD AIDS. 2004;15(1):7–16. doi:10.1258/095646204322637182
   PubMed Web of Science ®Google Scholar
• World Health Organization. Promoting rational use of medicines: core components. World Health Organization; 2002.
   Google Scholar